Company intelligence / Profile preview

TCGX Crossover Management

Palo Alto, CA, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

TCGX is a specialized investment firm focused on the life sciences and healthcare sectors. The firm primarily engages in crossover investing, providing capital to private biotechnology companies as they prepare for public market debuts. Founded by industry veteran Chen Yu, TCGX manages multi-billion dollar funds dedicated to supporting innovative therapeutic platforms and medical breakthroughs. The firm's investment strategy spans various stages of company maturity, with a focus on high-impact science and clinical-stage assets. TCGX operates offices in Palo Alto and New York, leveraging a team of experienced investors and scientists to identify and scale promising healthcare companies.

Industry: Investors

Beyond the preview

Go deeper on TCGX Crossover Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCGX Crossover Management.

Explore the full profile